_id
6911b298ccc777a4e85d5f47
Ticker
FLHLF
Name
Filament Health Corp
Exchange
PINK
Address
4475 Wayburne Drive, Burnaby, BC, Canada, V5G 4X4
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://filament.health
Description
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-03T11:46:57.517Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
5235879
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
6827
Cost Of Revenue
38148
Gross Profit
-31321
Operating Expenses
325546
Operating Income
-356868
Interest Expense
58387
Pretax Income
-460763
Net Income
-460763
Eps
-0.0017600214397604345
Dividends Per Share
-
Shares Outstanding
261793970
Income Tax Expense
-
EBITDA
-318633
Operating Margin
-5227.303354328402
Total Other Income Expense Net
-103895
Cash
242024
Short Term Investments
-
Receivables
141642
Inventories
-
Total Current Assets
385389
Property Plant Equipment
386123
Total Assets
2042577
Payables
1084931
Short Term Debt
103679
Long Term Debt
-
Total Liabilities
1665408
Equity
377169
Bs_currency_symbol
-
Depreciation
38148
Change In Working Capital
70085
Cash From Operations
-216426
Capital Expenditures
308
Cash From Investing
-305
Cash From Financing
-29462
Net Change In Cash
-257415
Cf_currency_symbol
-
PE
-
PB
0.06941025641025642
ROE
-122.16353942132041
ROA
-22.55792560084638
FCF
-216734
Fcf Percent
-31.74659440457009
Piotroski FScore
1
Health Score
16
Deep Value Investing Score
3.5
Defensive Investing Score
4
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
6827
Quarters > 0 > income Statement > cost Of Revenue
38148
Quarters > 0 > income Statement > gross Profit
-31321
Quarters > 0 > income Statement > operating Expenses
325546
Quarters > 0 > income Statement > operating Income
-356868
Quarters > 0 > income Statement > interest Expense
58387
Quarters > 0 > income Statement > pretax Income
-460763
Quarters > 0 > income Statement > net Income
-460763
Quarters > 0 > income Statement > eps
-0.0017600214397604345
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
261793970
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-318633
Quarters > 0 > income Statement > operating Margin
-5227.303354328402
Quarters > 0 > income Statement > total Other Income Expense Net
-103895
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
242024
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
141642
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
385389
Quarters > 0 > balance Sheet > property Plant Equipment
386123
Quarters > 0 > balance Sheet > total Assets
2042577
Quarters > 0 > balance Sheet > payables
1084931
Quarters > 0 > balance Sheet > short Term Debt
103679
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1665408
Quarters > 0 > balance Sheet > equity
377169
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-460763
Quarters > 0 > cash Flow > depreciation
38148
Quarters > 0 > cash Flow > change In Working Capital
70085
Quarters > 0 > cash Flow > cash From Operations
-216426
Quarters > 0 > cash Flow > capital Expenditures
308
Quarters > 0 > cash Flow > cash From Investing
-305
Quarters > 0 > cash Flow > cash From Financing
-29462
Quarters > 0 > cash Flow > net Change In Cash
-257415
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.0017600214397604345
Quarters > 0 > ratios > PB
0.06941025641025642
Quarters > 0 > ratios > ROE
-122.16353942132041
Quarters > 0 > ratios > ROA
-22.55792560084638
Quarters > 0 > ratios > FCF
-216734
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-31.74659440457009
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
155533
Quarters > 1 > income Statement > cost Of Revenue
39352
Quarters > 1 > income Statement > gross Profit
155533
Quarters > 1 > income Statement > operating Expenses
399191
Quarters > 1 > income Statement > operating Income
-324304
Quarters > 1 > income Statement > interest Expense
73960
Quarters > 1 > income Statement > pretax Income
-421652
Quarters > 1 > income Statement > net Income
-561895
Quarters > 1 > income Statement > eps
-0.0021463252190262443
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
261793970
Quarters > 1 > income Statement > income Tax Expense
-8941
Quarters > 1 > income Statement > EBITDA
-402207
Quarters > 1 > income Statement > operating Margin
-208.51137700680886
Quarters > 1 > income Statement > total Other Income Expense Net
-97348
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
679972
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
89627
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
793390
Quarters > 1 > balance Sheet > property Plant Equipment
590483
Quarters > 1 > balance Sheet > total Assets
3171578
Quarters > 1 > balance Sheet > payables
1498140
Quarters > 1 > balance Sheet > short Term Debt
321637
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2101856
Quarters > 1 > balance Sheet > equity
1069722
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-561895
Quarters > 1 > cash Flow > depreciation
53577
Quarters > 1 > cash Flow > change In Working Capital
49073
Quarters > 1 > cash Flow > cash From Operations
-370381
Quarters > 1 > cash Flow > capital Expenditures
1337
Quarters > 1 > cash Flow > cash From Investing
-1337
Quarters > 1 > cash Flow > cash From Financing
921249
Quarters > 1 > cash Flow > net Change In Cash
549531
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0021463252190262443
Quarters > 1 > ratios > PB
0.024473084595810875
Quarters > 1 > ratios > ROE
-52.52719865535158
Quarters > 1 > ratios > ROA
-17.716575155963373
Quarters > 1 > ratios > FCF
-371718
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.389962258813242
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
103480
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
103480
Quarters > 2 > income Statement > operating Expenses
897544
Quarters > 2 > income Statement > operating Income
-794064
Quarters > 2 > income Statement > interest Expense
6295
Quarters > 2 > income Statement > pretax Income
-847053
Quarters > 2 > income Statement > net Income
-847053
Quarters > 2 > income Statement > eps
-0.0032355710866831654
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
261793970
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-786917
Quarters > 2 > income Statement > operating Margin
-767.3598763045999
Quarters > 2 > income Statement > total Other Income Expense Net
-52989
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
130441
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
145414
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
290730
Quarters > 2 > balance Sheet > property Plant Equipment
642723
Quarters > 2 > balance Sheet > total Assets
2911346
Quarters > 2 > balance Sheet > payables
1622940
Quarters > 2 > balance Sheet > short Term Debt
180875
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1936969
Quarters > 2 > balance Sheet > equity
974377
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
-847053
Quarters > 2 > cash Flow > depreciation
53841
Quarters > 2 > cash Flow > change In Working Capital
450347
Quarters > 2 > cash Flow > cash From Operations
-221755
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-39041
Quarters > 2 > cash Flow > net Change In Cash
-260796
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
-0.0032355710866831654
Quarters > 2 > ratios > PB
0.026867831445118267
Quarters > 2 > ratios > ROE
-86.93277858570143
Quarters > 2 > ratios > ROA
-29.094892877727347
Quarters > 2 > ratios > FCF
-221755
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-2.142974487823734
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
190017
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
190017
Quarters > 3 > income Statement > operating Expenses
1280872
Quarters > 3 > income Statement > operating Income
-1090855
Quarters > 3 > income Statement > interest Expense
7105
Quarters > 3 > income Statement > pretax Income
-2055049
Quarters > 3 > income Statement > net Income
-2055049
Quarters > 3 > income Statement > eps
-0.008327159597448851
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
246788713
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1993802
Quarters > 3 > income Statement > operating Margin
-574.082845219112
Quarters > 3 > income Statement > total Other Income Expense Net
-964194
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
391237
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
272590
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
688640
Quarters > 3 > balance Sheet > property Plant Equipment
696564
Quarters > 3 > balance Sheet > total Assets
3412226
Quarters > 3 > balance Sheet > payables
1346517
Quarters > 3 > balance Sheet > short Term Debt
176428
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1664978
Quarters > 3 > balance Sheet > equity
1747248
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
-2055049
Quarters > 3 > cash Flow > depreciation
54142
Quarters > 3 > cash Flow > change In Working Capital
116795
Quarters > 3 > cash Flow > cash From Operations
-448429
Quarters > 3 > cash Flow > capital Expenditures
970
Quarters > 3 > cash Flow > cash From Investing
-970
Quarters > 3 > cash Flow > cash From Financing
-38081
Quarters > 3 > cash Flow > net Change In Cash
-487480
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
-0.008327159597448851
Quarters > 3 > ratios > PB
0.014124423836799356
Quarters > 3 > ratios > ROE
-117.61633151103908
Quarters > 3 > ratios > ROA
-60.226051850024
Quarters > 3 > ratios > FCF
-449399
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.365046285332365
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
616678
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
616678
Annuals > 0 > income Statement > operating Expenses
4285954
Annuals > 0 > income Statement > operating Income
-3669276
Annuals > 0 > income Statement > interest Expense
238812
Annuals > 0 > income Statement > pretax Income
-4970272
Annuals > 0 > income Statement > net Income
-4970272
Annuals > 0 > income Statement > eps
-0.020937735530052
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
237383455
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-4516392
Annuals > 0 > income Statement > operating Margin
-595.0067944697232
Annuals > 0 > income Statement > total Other Income Expense Net
-1300996
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
391237
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
272590
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
688640
Annuals > 0 > balance Sheet > property Plant Equipment
696564
Annuals > 0 > balance Sheet > total Assets
3412226
Annuals > 0 > balance Sheet > payables
1346517
Annuals > 0 > balance Sheet > short Term Debt
176428
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1664978
Annuals > 0 > balance Sheet > equity
1747248
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-4970272
Annuals > 0 > cash Flow > depreciation
215068
Annuals > 0 > cash Flow > change In Working Capital
196261
Annuals > 0 > cash Flow > cash From Operations
-2288927
Annuals > 0 > cash Flow > capital Expenditures
50478
Annuals > 0 > cash Flow > cash From Investing
-50478
Annuals > 0 > cash Flow > cash From Financing
902424
Annuals > 0 > cash Flow > net Change In Cash
-1436981
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.020937735530052
Annuals > 0 > ratios > PB
0.013586134023332693
Annuals > 0 > ratios > ROE
-284.4628810563812
Annuals > 0 > ratios > ROA
-145.6606918767983
Annuals > 0 > ratios > FCF
-2339405
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-3.79356001024846
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2130974
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
2130974
Annuals > 1 > income Statement > operating Expenses
7050618
Annuals > 1 > income Statement > operating Income
-4919644
Annuals > 1 > income Statement > interest Expense
374567
Annuals > 1 > income Statement > pretax Income
-5322032
Annuals > 1 > income Statement > net Income
-5322032
Annuals > 1 > income Statement > eps
-0.028356643247285648
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
187682017
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-4738668
Annuals > 1 > income Statement > operating Margin
-230.86363324939674
Annuals > 1 > income Statement > total Other Income Expense Net
-402388
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
1828218
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
881468
Annuals > 1 > balance Sheet > inventories
-294205
Annuals > 1 > balance Sheet > total Current Assets
2732073
Annuals > 1 > balance Sheet > property Plant Equipment
861154
Annuals > 1 > balance Sheet > total Assets
5576109
Annuals > 1 > balance Sheet > payables
1425511
Annuals > 1 > balance Sheet > short Term Debt
159704
Annuals > 1 > balance Sheet > long Term Debt
1045644
Annuals > 1 > balance Sheet > total Liabilities
3084540
Annuals > 1 > balance Sheet > equity
2491569
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-5322032
Annuals > 1 > cash Flow > depreciation
208797
Annuals > 1 > cash Flow > change In Working Capital
739923
Annuals > 1 > cash Flow > cash From Operations
-4187625
Annuals > 1 > cash Flow > capital Expenditures
57652
Annuals > 1 > cash Flow > cash From Investing
-57652
Annuals > 1 > cash Flow > cash From Financing
3226755
Annuals > 1 > cash Flow > net Change In Cash
-1018522
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.028356643247285648
Annuals > 1 > ratios > PB
0.007532683903195135
Annuals > 1 > ratios > ROE
-213.60163013747564
Annuals > 1 > ratios > ROA
-95.44347142424941
Annuals > 1 > ratios > FCF
-4245277
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.9921768167983278
Annuals > 1 > health Score
23
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
364500
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
364500
Annuals > 2 > income Statement > operating Expenses
5879048
Annuals > 2 > income Statement > operating Income
-5500900
Annuals > 2 > income Statement > interest Expense
184670
Annuals > 2 > income Statement > pretax Income
-16537003
Annuals > 2 > income Statement > net Income
-16466465
Annuals > 2 > income Statement > eps
-0.09706320248805822
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
169646834
Annuals > 2 > income Statement > income Tax Expense
-70538
Annuals > 2 > income Statement > EBITDA
-5155089
Annuals > 2 > income Statement > operating Margin
-1509.1632373113855
Annuals > 2 > income Statement > total Other Income Expense Net
-11036103
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
2846740
Annuals > 2 > balance Sheet > short Term Investments
1803000
Annuals > 2 > balance Sheet > receivables
55757
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
3172464
Annuals > 2 > balance Sheet > property Plant Equipment
1012299
Annuals > 2 > balance Sheet > total Assets
4740657
Annuals > 2 > balance Sheet > payables
252278
Annuals > 2 > balance Sheet > short Term Debt
123245
Annuals > 2 > balance Sheet > long Term Debt
719190
Annuals > 2 > balance Sheet > total Liabilities
1547335
Annuals > 2 > balance Sheet > equity
3193322
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-16466465
Annuals > 2 > cash Flow > depreciation
200645
Annuals > 2 > cash Flow > change In Working Capital
281034
Annuals > 2 > cash Flow > cash From Operations
-3925984
Annuals > 2 > cash Flow > capital Expenditures
32156
Annuals > 2 > cash Flow > cash From Investing
-70857
Annuals > 2 > cash Flow > cash From Financing
2214516
Annuals > 2 > cash Flow > net Change In Cash
-1782325
Annuals > 2 > cash Flow > currency_symbol
CAD
Annuals > 2 > ratios > PE
-0.09706320248805822
Annuals > 2 > ratios > PB
0.005312550190679174
Annuals > 2 > ratios > ROE
-515.653134885865
Annuals > 2 > ratios > ROA
-347.3456316286962
Annuals > 2 > ratios > FCF
-3958140
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-10.859094650205762
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
162500
Annuals > 3 > income Statement > cost Of Revenue
913647
Annuals > 3 > income Statement > gross Profit
-913647
Annuals > 3 > income Statement > operating Expenses
6355276
Annuals > 3 > income Statement > operating Income
-7096833
Annuals > 3 > income Statement > interest Expense
40083
Annuals > 3 > income Statement > pretax Income
-9291355
Annuals > 3 > income Statement > net Income
-9253607
Annuals > 3 > income Statement > eps
-0.06293356951766688
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
147037695
Annuals > 3 > income Statement > income Tax Expense
-37748
Annuals > 3 > income Statement > EBITDA
-7078083
Annuals > 3 > income Statement > operating Margin
-4367.281846153846
Annuals > 3 > income Statement > total Other Income Expense Net
-2194522
Annuals > 3 > income Statement > currency_symbol
CAD
Annuals > 3 > balance Sheet > cash
4629065
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
126302
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
5343738
Annuals > 3 > balance Sheet > property Plant Equipment
1180788
Annuals > 3 > balance Sheet > total Assets
17842088
Annuals > 3 > balance Sheet > payables
369421
Annuals > 3 > balance Sheet > short Term Debt
385564
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1289530
Annuals > 3 > balance Sheet > equity
16552558
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-9253607
Annuals > 3 > cash Flow > depreciation
134342
Annuals > 3 > cash Flow > change In Working Capital
-514644
Annuals > 3 > cash Flow > cash From Operations
-5407222
Annuals > 3 > cash Flow > capital Expenditures
130476
Annuals > 3 > cash Flow > cash From Investing
-265780
Annuals > 3 > cash Flow > cash From Financing
9423637
Annuals > 3 > cash Flow > net Change In Cash
3750635
Annuals > 3 > cash Flow > currency_symbol
CAD
Annuals > 3 > ratios > PE
-0.06293356951766688
Annuals > 3 > ratios > PB
0.0008883079884088006
Annuals > 3 > ratios > ROE
-55.904392541624084
Annuals > 3 > ratios > ROA
-51.86392422232197
Annuals > 3 > ratios > FCF
-5537698
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-34.07814153846154
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.0017600214397604345
Valuation > metrics > PB
0.06941025641025642
Valuation > final Score
70
Valuation > verdict
93.1% Undervalued
Profitability > metrics > ROE
-122.16353942132041
Profitability > metrics > ROA
-119.55790123745098
Profitability > metrics > Net Margin
-67.49128460524389
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
4.415548467663037
Risk > metrics > Interest Coverage
-6.1121139979790025
Risk > final Score
-18
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.3242350308343359
Liquidity > metrics > Quick Ratio
0.3242350308343359
Liquidity > final Score
26
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
12
Prev Risks > 1
-475
Prev Risks > 2
-566
Prev Liquidities > 0
32
Prev Liquidities > 1
18
Prev Liquidities > 2
33
Updated At
2026-01-20T21:50:16.604Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0018
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-19
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0016
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-20
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0023
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-29
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.0028
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-08-14
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
CAD
Earnings History > 4 > eps Actual
-0.0034
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-05-16
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
CAD
Earnings History > 5 > eps Actual
-0.0032
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-16
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
CAD
Earnings History > 6 > eps Actual
-0.0056
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-16
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CAD
Earnings History > 7 > eps Actual
-0.0065
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-12
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CAD
Earnings History > 8 > eps Actual
-0.0053
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-31
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
CAD
Earnings History > 9 > eps Actual
-0.07
Earnings History > 9 > eps Estimate
-0.02
Earnings History > 9 > eps Difference
-0.05
Earnings History > 9 > surprise Percent
-250
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-10
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
CAD
Earnings History > 10 > eps Actual
-0.01
Earnings History > 10 > eps Estimate
-0.02
Earnings History > 10 > eps Difference
0.01
Earnings History > 10 > surprise Percent
50
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-15
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CAD
Earnings History > 11 > eps Actual
-0.01
Earnings History > 11 > eps Estimate
-0.01
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-05-17
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
CAD
Earnings History > 12 > eps Actual
-0.01
Earnings History > 12 > eps Estimate
-0.01
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-03-31
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
CAD
Earnings History > 13 > eps Actual
-0.01
Earnings History > 13 > eps Estimate
-0.01
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-11-15
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CAD
Earnings History > 14 > eps Actual
-0.008
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company in Canada. The company's leading drug candidates comprises PEX010 oral psilocybin, PEX020 oral psilocin, and PEX030 sublingual psilocin. It also develops AEX010 ayahuasca, which is in preclinical stage; and AEX020 monoamine oxidase inhibitor and is in preclinical stage. In addition, the company provides in-house human clinical trials, as well as license technology to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFILAMENT HEALTH ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS Yahoo! Finance Canada
Read more →FILAMENT HEALTH ANNOUNCES TRANSITION FROM OTCQB TO OTC PINK LIMITED - Yahoo! Finance Canada
5/27/2025
FILAMENT HEALTH ANNOUNCES TRANSITION FROM OTCQB TO OTC PINK LIMITED Yahoo! Finance Canada
Read more →Showing 2 of 3
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Filament Health Corp
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0018
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.